{"id":10121,"date":"2026-01-29T12:18:04","date_gmt":"2026-01-29T11:18:04","guid":{"rendered":"https:\/\/galenika.com\/?p=10121"},"modified":"2026-01-29T12:23:34","modified_gmt":"2026-01-29T11:23:34","slug":"galenika-acquires-slovenian-company-sanofarm-strengthening-market-presence-in-the-adria-region","status":"publish","type":"post","link":"https:\/\/galenika.com\/en\/galenika-acquires-slovenian-company-sanofarm-strengthening-market-presence-in-the-adria-region\/","title":{"rendered":"Galenika acquires slovenian company Sanofarm &#8211; Strengthening market presence in the Adria Region"},"content":{"rendered":"<p><em><strong>Belgrade, January 29, 2026<\/strong> \u2013 <strong>Pharmaceutical company Galenika has acquired a 100% ownership stake in the Slovenian company Sanofarm, further strengthening its position in the Slovenian and Croatian markets and continuing its strategic expansion within the European Union. Through this acquisition, Galenika also assumes exclusive distribution of products from renowned Italian manufacturers Pharmalife Research and ESI in Slovenia, as well as the Pharmalife brand in Croatia<\/strong><strong>.<\/strong><\/em><\/p>\n<blockquote><p><em>Since becoming part of brazilian NC Group, Galenika has been continuously strengthening its international presence and developing its portfolio in line with the evolving needs of consumers. We are strategically focused on expanding our portfolio in the segment of natural products and dietary supplements. The acquisition of Sanofarm represents an important step in the further internationalization of our business and the continuation of our partnership with Pharmalife Research, while also broadening our offering to include products from the Italian brand ESI, a renowned manufacturer of phytotherapeutic and dietary products<\/em>,\u201d said Ricardo Vian Marques, General Manager of Galenika.<\/p><\/blockquote>\n<p>Sanofarm is an established distributor of dietary supplements and phytotherapeutic products, with a strong presence in Slovenia and Croatia. By integrating Sanofarm\u2019s portfolio with Galenika\u2019s products, the company aims to create additional synergies, increase the availability of high-quality products, and further enhance the offering for consumers in these markets.<\/p>\n<p>This acquisition enables Galenika to further strengthen its presence in the EU, increase the visibility of well-known brands, and contribute to a more diverse and higher-quality product offering for consumers across the Adria region. Galenika will continue to uphold Sanofarm\u2019s strong business practices toward employees and partners, while advancing corporate governance and supporting long-term sustainable growth.<\/p>\n<p>&nbsp;<\/p>\n<p>***<\/p>\n<p><strong><em>Pharmaceutical company Galenika <\/em><\/strong><em>(<\/em><a href=\"http:\/\/www.galenika.com\"><em>www.galenika.com<\/em><\/a><em>) was founded in 1945. At the end of 2017, it became part of the NC Group (<\/em><a href=\"http:\/\/www.gruponc.net.br\" target=\"_blank\" rel=\"noopener\"><em>www.gruponc.net.br<\/em><\/a><em>), which also includes EMS &#8211; the largest pharmaceutical company in Brazil and one of the largest pharmaceutical companies in the Latin America. With a portfolio of over 330 products, Galenika manufactures generic drugs, dietary supplements, cosmetic products and medical devices. The Group&#8217;s strategy is the development of Galenika as a modern and flexible company, focused on research and development, which constantly works on expanding its portfolio to enhance health and quality of life.<\/em><\/p>\n<p><strong><em>Sanofarm <\/em><\/strong><em>(<\/em><a href=\"https:\/\/sanofarm.si\/\" target=\"_blank\" rel=\"noopener\"><em>https:\/\/sanofarm.si\/<\/em><\/a><em>)<\/em> <em>is a Slovenian company headquartered in Izola, specializing in the distribution of dietary supplements and phytotherapeutic products from renowned Italian manufacturers Pharmalife Research and ESI. The company operates in the Slovenian and Croatian markets and is recognized as a reliable partner with a well-developed distribution network and a strong retail presence, with a clear focus on product quality and the needs of end consumers.<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Belgrade, January 29, 2026 \u2013 Pharmaceutical company Galenika has&#8230;<\/p>\n","protected":false},"author":11,"featured_media":10112,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[73],"tags":[],"class_list":["post-10121","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-vesti-en"],"acf":[],"_links":{"self":[{"href":"https:\/\/galenika.com\/en\/wp-json\/wp\/v2\/posts\/10121","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/galenika.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/galenika.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/galenika.com\/en\/wp-json\/wp\/v2\/users\/11"}],"replies":[{"embeddable":true,"href":"https:\/\/galenika.com\/en\/wp-json\/wp\/v2\/comments?post=10121"}],"version-history":[{"count":2,"href":"https:\/\/galenika.com\/en\/wp-json\/wp\/v2\/posts\/10121\/revisions"}],"predecessor-version":[{"id":10123,"href":"https:\/\/galenika.com\/en\/wp-json\/wp\/v2\/posts\/10121\/revisions\/10123"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/galenika.com\/en\/wp-json\/wp\/v2\/media\/10112"}],"wp:attachment":[{"href":"https:\/\/galenika.com\/en\/wp-json\/wp\/v2\/media?parent=10121"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/galenika.com\/en\/wp-json\/wp\/v2\/categories?post=10121"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/galenika.com\/en\/wp-json\/wp\/v2\/tags?post=10121"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}